Merck logo

Merck

Europe, Hessen, Germany, Darmstadt

Description

Merck is a pharmaceutical and chemical enterprise that develops prescription drugs and over-the-counter products.

Investor Profile

Merck has made 14 investments, with 1 in the past 12 months and 57% as lead.

Stage Focus

  • Grant (21%)
  • Series A (14%)
  • Seed (14%)
  • Series Unknown (14%)
  • Post Ipo Equity (14%)
  • Series B (7%)
  • Series C (7%)
  • Series H (7%)

Country Focus

  • United States (71%)
  • Germany (7%)
  • China (7%)
  • United Kingdom (7%)
  • The Netherlands (7%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Medical
  • Life Science
  • Therapeutics
  • Biopharma
  • Oncology
  • Artificial Intelligence (Ai)
  • Big Data
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Merck frequently co-invest with?

EcoR1 Capital
North America, California, United States, San Francisco
Co-Investments: 1
Bristol-Myers Squibb
North America, New York, United States, New York
Co-Investments: 1
NS Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
MPM Capital
North America, Massachusetts, United States, Boston
Co-Investments: 2
MRL Ventures Fund
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
Mirae Asset Venture Investment
Asia, Kyonggi-do, South Korea, Seongnam
Co-Investments: 1
Novartis
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 1
CH
North America, New York, United States, New York
Co-Investments: 1
ArrowMark Partners
North America, Colorado, United States, Denver
Co-Investments: 1
Octagon Capital Advisors
North America, New York, United States, New York
Co-Investments: 1

What are some of recent deals done by Merck?

Ambrosia Biosciences

Boulder, Colorado, United States

Ambrosia Biosciences offers drug development services for small molecule-based therapies for obesity and other metabolic disorders.

BiopharmaBiotechnologyHealth Care
Series ADec 10, 2024
Amount Raised: $25,000,000
Proteologix

Redwood City, California, United States

Proteologix is a biotech company that develops drugs for treatment of autoimmune/inflammatory diseases and oncology.

BiopharmaBiotechnologyLife ScienceOncology
GrantJun 6, 2023
Eurocine Vaccines

Sweden, South Carolina, United States

Eurocine Vaccines creates nasal flu vaccines designed for children and the elderly.

Clinical TrialsManufacturingPharmaceuticalTherapeutics
GrantMay 4, 2023
Amount Raised: $29,325
Aktis Oncology

Boston, Massachusetts, United States

Aktis Oncology is a biotechnology company discovering and developing a novel class of targeted radiopharmaceuticals.

BiotechnologyHealth CareLife ScienceOncology
Series AAug 25, 2022
Amount Raised: $84,000,000
Orna Therapeutics

Cambridge, Massachusetts, United States

Orna Therapeutics is a biotechnology company that specializes in fully engineered circular RNA therapeutics to treat various diseases.

BiotechnologyMedicalPharmaceuticalTherapeutics
Series BAug 16, 2022
Amount Raised: $221,000,000
Artios Pharma

Cambridge, Cambridgeshire, United Kingdom

Artios Pharma is a independent DNA Damage Response company with a strong pipeline of novel cancer therapies.

BiopharmaBiotechnologyMedical Device
Series UnknownDec 3, 2020
Amount Raised: $30,000,000
Formo

Berlin, Berlin, Germany

Formo is a cell-ag company that develops animal-free dairy products using nature-identical milk proteins from precision fermentation.

BiotechnologyFood and BeverageLife Science
SeedDec 19, 2019
Amount Raised: $4,700,000
Mosaic

Hongkou, Shanghai, China

Mosaic is a technology company that provides children's precise development and professional rehabilitation services.

Child CareMedicalRehabilitation
Series UnknownJul 17, 2018
Amount Raised: $8,800,000
Moderna

Cambridge, Massachusetts, United States

Moderna Therapeutics is a biotechnology company that specializes in vaccines and drug development.

BiotechnologyGeneticsHealth CareMedicalPharmaceuticalTherapeutics
Series HMay 3, 2018
Amount Raised: $125,000,000
RxAll

New Haven, Connecticut, United States

RxAll is a Deep Learning-Hyperspectral IoT Platform for the authentication and real-time global tracking of quality of drugs.

Artificial Intelligence (AI)Big DataDatabaseDelivery ServiceEnterpriseHardwareInternet of ThingsSoftware
GrantAug 31, 2017
Amount Raised: $60,000